FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC Enanta Pharmaceuticals, Inc. Transaction History

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC portfolio value:

$1.18M
portfolio value

FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC quarter portfolio value change:

+9.73%
quarter

Enanta Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 105K $51.87 22.75K
Q2 2022 share 0.00% 0 shares -544K $47.27 22.75K
Q1 2022 share Increase 0.00% 22.75K shares 1.61M $71.18 22.75K